Diagnostic Antibodies and Proteins Detected with DNA Nanomachines
By LabMedica International staff writers Posted on 27 Oct 2015 |
Image: The light-generating DNA antibody detecting nanomachine is illustrated here in action, bound to an antibody (Photo courtesy of Marco Tripodi).
A nanoscale machine composed of synthetic DNA can be used for the rapid, sensitive and low-cost diagnosis of many infectious and autoimmune diseases, including human immunodeficiency virus (HIV) and rheumatoid arthritis (RA).
A versatile platform for the one-step fluorescence detection of both monovalent and multivalent proteins has been developed and is based on a conformation-switching stem-loop DNA scaffold that presents a small-molecule, polypeptide, or nucleic-acid recognition element on each of its two stem strands.
Scientists at the University of Rome Tor Vergata (Italy) working with their North American colleagues designed and synthetized a nanometer-scale DNA "machine" whose customized modifications enable it to recognize a specific target antibody. Their new approach promises to support the development of rapid, low-cost antibody detection at the point-of-care, eliminating the treatment initiation delays and increasing healthcare costs associated with current techniques. The protein-targeting sensor is composed of a fluorophore/quencher-modified DNA stem–loop system containing two single-stranded tails. To create a target-responsive sensor, these tails are hybridized with DNAs conjugated to an appropriate recognition element.
The binding of the antibody to the DNA machine causes a structural change or switch, which generates a light signal. The sensor does not need to be chemically activated and is rapid, acting within five minutes, enabling the targeted antibodies to be easily detected, even in complex clinical samples such as blood serum. The versatility of the platform was demonstrated by detecting five bivalent proteins (four antibodies and the chemokine platelet-derived growth factor) and two monovalent proteins (a Fab fragment and the transcription factor TATA Box Binding Protein (TBP) with low nanomolar detection limits and no detectable cross-reactivity.
Francesco Ricci, PhD, a professor and senior coauthor of the study, said, “One of the advantages of our approach is that it is highly versatile. This DNA nanomachine can be in fact custom-modified so that it can detect a huge range of antibodies; this makes our platform adaptable for many different diseases.” The materials needed for one assay cost about USD 0.15, making the approach very competitive in comparison with other quantitative approaches. The study was published on September 4, 2015, in the journal Angewandte Chemie.
Related Links:
University of Rome Tor Vergata
A versatile platform for the one-step fluorescence detection of both monovalent and multivalent proteins has been developed and is based on a conformation-switching stem-loop DNA scaffold that presents a small-molecule, polypeptide, or nucleic-acid recognition element on each of its two stem strands.
Scientists at the University of Rome Tor Vergata (Italy) working with their North American colleagues designed and synthetized a nanometer-scale DNA "machine" whose customized modifications enable it to recognize a specific target antibody. Their new approach promises to support the development of rapid, low-cost antibody detection at the point-of-care, eliminating the treatment initiation delays and increasing healthcare costs associated with current techniques. The protein-targeting sensor is composed of a fluorophore/quencher-modified DNA stem–loop system containing two single-stranded tails. To create a target-responsive sensor, these tails are hybridized with DNAs conjugated to an appropriate recognition element.
The binding of the antibody to the DNA machine causes a structural change or switch, which generates a light signal. The sensor does not need to be chemically activated and is rapid, acting within five minutes, enabling the targeted antibodies to be easily detected, even in complex clinical samples such as blood serum. The versatility of the platform was demonstrated by detecting five bivalent proteins (four antibodies and the chemokine platelet-derived growth factor) and two monovalent proteins (a Fab fragment and the transcription factor TATA Box Binding Protein (TBP) with low nanomolar detection limits and no detectable cross-reactivity.
Francesco Ricci, PhD, a professor and senior coauthor of the study, said, “One of the advantages of our approach is that it is highly versatile. This DNA nanomachine can be in fact custom-modified so that it can detect a huge range of antibodies; this makes our platform adaptable for many different diseases.” The materials needed for one assay cost about USD 0.15, making the approach very competitive in comparison with other quantitative approaches. The study was published on September 4, 2015, in the journal Angewandte Chemie.
Related Links:
University of Rome Tor Vergata
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability